OSS.png
One Stop Systems Announces Annual Meeting of Shareholders
May 01, 2024 08:31 ET | One Stop Systems, Inc.
ESCONDIDO, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (“OSS” or the "Company") (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI),...
Neuronetics_logo-RGB purple.png
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
May 01, 2024 08:31 ET | Neuronetics
MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) --  Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Motorsport Games Announces Sale of Traxion
Motorsport Games Announces Sale of Traxion
May 01, 2024 08:30 ET | Motorsport Games Inc.
MIAMI, May 01, 2024 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (the “Company” or “Motorsport Games”), a racing game developer, publisher, and esports ecosystem provider of official...
FINAL_VeruIncLogo_RGB_300dpi.jpg
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
May 01, 2024 08:30 ET | Veru Inc.
MIAMI, FL, May 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high...
Runway-Growth-Finance-Corp-Logo_Horizontal.png
Runway Growth Finance Corp. Announces Second Quarter Regular Dividend of $0.40 and $0.07 Supplemental Distribution
May 01, 2024 08:30 ET | Runway Growth Finance Corp.
MENLO PARK, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and...
Aileron-logo.png
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
May 01, 2024 08:30 ET | Aileron Therapeutics, Inc.
Low-dose LTI-03 (2.5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both pathological basal-like cells and fibroblasts and increased the expression of a...
Bridgeline_Finance_Yahoo 1200x628 (1).jpg
Voltus GmbH Selects Bridgeline's AI-Powered Site Search
May 01, 2024 08:30 ET | Bridgeline Digital, Inc.
WOBURN, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of marketing technology software, announced today that Voltus GmbH, a leading German electrical...
logo. ver 2.png
Earlyworks Co., Ltd. Reports Financial and Operational Performance for the Six Months Ended October 31, 2023
May 01, 2024 08:30 ET | EARLYWORKS CO., LTD.
TOKYO, May 01, 2024 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (NASDAQ: ELWS) (the “Company”), a Japanese provider of blockchain technology solutions, yesterday announced its financial results for the...
yield10.png
Yield10 Bioscience Announces 1-for-24 Reverse Stock Split
May 01, 2024 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that it will effect a...
Palisade Bio_Logos(4.22)VSM.png
Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)
May 01, 2024 08:30 ET | Palisade Bio, Inc.
Company on track to commence Phase 1 human clinical study of PALI-2108 for the treatment of Ulcerative Colitis (UC) before year end Carlsbad, CA, May 01, 2024 (GLOBE NEWSWIRE) -- Palisade...